Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Sorrento Therpt (NQ: SRNE )

9.500 USD +1.510 (+18.90%)
Official Closing Price Updated: 7:59 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Sorrento Therpt

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
18 19 Next >
SORRENTO ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Sorrento Therapeutics, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Southern District of... 
From Business Wire News Releases
SRNE INVESTOR ALERT: Kirby McInerney LLP Announces That it has Filed a Class Action Lawsuit Against Sorrento Therapeutics, Inc. and Encourages Investors to Contact the Firm Before July 27
From GlobeNewswire News Releases
Thinking about trading stocks or options in Splunk, Carnival Corp, Sorrento Therapeutics, Boeing, or Eldorado Resorts?
InvestorsObserver issues critical PriceWatch Alerts for SPLK, CCL, SRNE, BA, and ERI. 
From PR Newswire
Sorrento Receives FDA IND Clearance to Initiate a Phase I Clinical Trial of its CD38 Antibody-Drug Conjugate (ADC) STI-6129 for Patients with Amyloidosis
From GlobeNewswire News Releases
SORRENTO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Sorrento Therapeutics, Inc. To Contact The Firm
From NewMediaWire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sorrento Therapeutics, Inc. - SRNE
From GlobeNewswire News Releases
Sorrento Enters Into Binding Term Sheet to Acquire Exclusive Rights to Abivertinib with Completed Registrational Trial Data in Non-Small Cell Lung Cancer
From GlobeNewswire News Releases
Thinking about buying stock in Kitov Pharma, Sorrento Therapeutics, Seanergy Maritime Holdings, Moderna, or MGM Resorts?
InvestorsObserver issues critical PriceWatch Alerts for KTOV, SRNE, SHIP, MRNA, and MGM. 
From PR Newswire
COVID-19 Treatments And Vaccine Developments Picking Up Welcomed Pace
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
COVID-19 Treatments and Vaccine Developments Picking Up Welcomed Pace
Financialnewsmedia.com News Commentary 
From PR Newswire
Thinking about buying stock in Sorrento Therapeutics, Chesapeake Energy Corp, Trevena, Delta Air Lines, or Royal Caribbean Cruises?
InvestorsObserver issues critical PriceWatch Alerts for SRNE, CHK, TRVN, DAL, and RCL. 
From PR Newswire
STI-1499, A Potent Anti-SARS-CoV-2 Antibody, Demonstrates Ability To Completely Inhibit In Vitro Virus Infection In Preclinical Studies
STI-1499 Antibody has demonstrated in preclinical experiments (full results will be submitted to a peer-reviewed publication shortly): 
From PR Newswire
Thinking about buying stock in Sorrento Therapeutics, Cassava Sciences, Diffusion Pharma, Onconova Therapeutics, or Bridgeline Digital?
InvestorsObserver issues critical PriceWatch Alerts for SRNE, SAVA, DFFN, ONTX, and BLIN. 
From PR Newswire
Thinking about buying stock in Capricor Therapeutics, Waitr, Takeda Pharmaceutical, Sorrento Therapeutics, or Inovio Pharmaceuticals?
InvestorsObserver issues critical PriceWatch Alerts for CAPR, WTRH, TAK, SRNE, and INO. 
From PR Newswire
Sorrento And Mount Sinai Health System To Jointly Develop COVI-SHIELD™ Antibody Therapy Targeting SARS-CoV-2 Infection (COVID-19)
From PR Newswire
FDA Allows Expanded Use Of Remote Devices To Monitor Patients’ Vital Signs In Global COVID-19 Health Crisis
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
FDA Allows Expanded Use of Remote Devices to Monitor Patients' Vital Signs in Global COVID-19 Health Crisis
Financialnewsmedia.com News Commentary 
From PR Newswire
SORRENTO TO PROVIDE MANUFACTURING SUPPORT TO CELULARITY AS CYNK-001 NK CELL TRIAL FOR COVID-19 BEGINS ENROLLING PATIENTS
From GlobeNewswire News Releases
SORRENTO AND THE UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON ENTER INTO PRECLINICAL TESTING AGREEMENT FOR COVID-19 THERAPEUTIC CANDIDATES
From GlobeNewswire News Releases
Sorrento Launches Novel I-Cell™ COVID-19 Cellular Vaccine Program
From GlobeNewswire News Releases
SORRENTO COLLABORATES WITH MABPHARM ON DEVELOPMENT AND COMMERCIALIZATION OF ACE-MAB™ TO POTENTIALLY TREAT COVID-19
From GlobeNewswire News Releases
SORRENTO AND SMARTPHARM TO COLLABORATE TO DEVELOP NOVEL GENE-ENCODED ANTIBODY VACCINE INTENDED TO PROTECT AGAINST COVID-19
Collaboration to leverage synergies between Monoclonal Antibody and Non-Viral Gene Delivery Platforms 
From GlobeNewswire News Releases
Biotechs and Big Pharma in a Race Against Time Battling Global Health Crisis
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Biotechs and Big Pharma in a Race Against Time Battling Global Health Crisis
Financialnewsmedia.com News Commentary 
From PR Newswire
SORRENTO DEVELOPS STI-4398 (COVIDTRAP™ PROTEIN) FOR POTENTIAL PREVENTION AND TREATMENT OF SARS-COV-2 CORONAVIRUS DISEASE (COVID-19)
From GlobeNewswire News Releases
ServiceSource Announces Four New Appointments to Board of Directors
ServiceSource (NASDAQ: SREV) Announces Four New Appointments to Board of Directors 
From Business Wire News Releases
Sorrento Therapeutics Presents Interim Positive Results of Phase 1b Resiniferatoxin (RTX) in Cancer Pain Trial
From GlobeNewswire News Releases
Sorrento to Provide Corporate Update, Including DAR-T Cell Therapy Advances, at LEERINK Global Healthcare Conference
From GlobeNewswire News Releases
Sorrento Therapeutics CEO Dr. Ji to Present at LEERINK Partners 9th Global Healthcare Conference
From GlobeNewswire News Releases
CBD Helps Establish the Wellness Category for Cannabis Products
FinancialBuzz.com News Commentary 
From PR Newswire
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
18 19 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.